Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy S C Hinks

Showing results (21-30 of 67) with videos related to

Pageof 7
Sort By:
Respirology (Carlton, Vic.)|May 20, 2022
Sub-stratification of type-2 high airway disease for therapeutic decision-making: A 'bomb' (blood eosinophils) meets 'magnet' (FeNO) frameworkSimon Couillard, Ian D Pavord, Liam G Heaney, et al.
ERJ Open Research|February 10, 2022
Predicting the benefits of type-2 targeted anti-inflammatory treatment with the prototype Oxford Asthma Attack Risk Scale (ORACLE)Simon Couillard, William Il Hoon Do, Richard Beasley, et al.
The Journal of Infectious Diseases|October 21, 2010
Mycobacterium tuberculosis-specific cellular immune profiles suggest bacillary persistence decades after spontaneous cure in untreated tuberculosisKerry A Millington, Sarah Gooding, Timothy S C Hinks, et al.
The Journal of Allergy and Clinical Immunology|September 18, 2012
Phenotypic characterization of lung macrophages in asthmatic patients: overexpression of CCL17Karl J Staples, Timothy S C Hinks, Jon A Ward, et al.
American Journal of Respiratory and Critical Care Medicine|April 27, 2016
Steroid-induced Deficiency of Mucosal-associated Invariant T Cells in the Chronic Obstructive Pulmonary Disease Lung. Implications for Nontypeable Haemophilus influenzae InfectionTimothy S C Hinks, Joshua C Wallington, Anthony P Williams, et al.
JMIR Research Protocols|June 23, 2023
Recovery of Breakthrough Asthma Attacks Treated With Oral Steroids While on Monoclonal Antibody Therapy: Protocol for a Prospective Observational Study (BOOST)Imran Howell, Mahdi Mahdi, Mona Bafadhel, et al.
Methods in Molecular Biology (Clifton, N.J.)|December 4, 2019
Study of MAIT Cell Activation in Viral Infections In VivoTimothy S C Hinks, Bonnie van Wilgenburg, Huimeng Wang, et al.
The Journal of Allergy and Clinical Immunology|May 26, 2020
ACE2, TMPRSS2, and furin gene expression in the airways of people with asthma-implications for COVID-19Peter Bradding, Matthew Richardson, Timothy S C Hinks, et al.
BMC Infectious Diseases|December 11, 2012
High background rates of positive tuberculosis-specific interferon-γ release assays in a low prevalence region of UK: a surveillance studyTimothy S C Hinks, Nimu Varsani, David T Godsiff, et al.
Frontiers in Cellular and Infection Microbiology|May 14, 2023
Epithelial immune activation and intracellular invasion by non-typeable <i>Haemophilus influenzae</i>Mary A Brown, Sophie B Morgan, Gillian E Donachie, et al.
Pageof 7

Showing results (21-30 of 67) with videos related to

Sort By:
Pageof 7
Respirology (Carlton, Vic.)|May 20, 2022
Sub-stratification of type-2 high airway disease for therapeutic decision-making: A 'bomb' (blood eosinophils) meets 'magnet' (FeNO) frameworkSimon Couillard, Ian D Pavord, Liam G Heaney, et al.
ERJ Open Research|February 10, 2022
Predicting the benefits of type-2 targeted anti-inflammatory treatment with the prototype Oxford Asthma Attack Risk Scale (ORACLE)Simon Couillard, William Il Hoon Do, Richard Beasley, et al.
The Journal of Infectious Diseases|October 21, 2010
Mycobacterium tuberculosis-specific cellular immune profiles suggest bacillary persistence decades after spontaneous cure in untreated tuberculosisKerry A Millington, Sarah Gooding, Timothy S C Hinks, et al.
The Journal of Allergy and Clinical Immunology|September 18, 2012
Phenotypic characterization of lung macrophages in asthmatic patients: overexpression of CCL17Karl J Staples, Timothy S C Hinks, Jon A Ward, et al.
American Journal of Respiratory and Critical Care Medicine|April 27, 2016
Steroid-induced Deficiency of Mucosal-associated Invariant T Cells in the Chronic Obstructive Pulmonary Disease Lung. Implications for Nontypeable Haemophilus influenzae InfectionTimothy S C Hinks, Joshua C Wallington, Anthony P Williams, et al.
JMIR Research Protocols|June 23, 2023
Recovery of Breakthrough Asthma Attacks Treated With Oral Steroids While on Monoclonal Antibody Therapy: Protocol for a Prospective Observational Study (BOOST)Imran Howell, Mahdi Mahdi, Mona Bafadhel, et al.
Methods in Molecular Biology (Clifton, N.J.)|December 4, 2019
Study of MAIT Cell Activation in Viral Infections In VivoTimothy S C Hinks, Bonnie van Wilgenburg, Huimeng Wang, et al.
The Journal of Allergy and Clinical Immunology|May 26, 2020
ACE2, TMPRSS2, and furin gene expression in the airways of people with asthma-implications for COVID-19Peter Bradding, Matthew Richardson, Timothy S C Hinks, et al.
BMC Infectious Diseases|December 11, 2012
High background rates of positive tuberculosis-specific interferon-γ release assays in a low prevalence region of UK: a surveillance studyTimothy S C Hinks, Nimu Varsani, David T Godsiff, et al.
Frontiers in Cellular and Infection Microbiology|May 14, 2023
Epithelial immune activation and intracellular invasion by non-typeable <i>Haemophilus influenzae</i>Mary A Brown, Sophie B Morgan, Gillian E Donachie, et al.
Pageof 7